²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma | MicrobiomeTrials
²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma
WITHDRAWNPHASE1INTERVENTIONAL
Trial Details
Start: 2027-06-01Est. Completion: 2028-12-31
Enrollment target: 0 participants
Locations
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Other microbiome trials you might be interested in